IBM's market value drops $50 billion after revenue warning IBM's market value plummeted over $50 billion after issuing a preliminary revenue warning for the second quarter. The warning led to a historic single-day drop, the worst for the company since 1987.
Shares of Axsome Therapeutics were up in the premarket on Wednesday after the company announced that the U.S. FDA accepted its marketing application for AXS-12 (reboxetine), an experimental therapy for patients with the sleeping disorder narcolepsy The neurology dru
Nvidia and Meta report surging demand in AI and digital advertising, driving revenue growth and analyst upgrades. Nvidia reported an 85% year-over-year revenue surge to $82 billion in its fiscal 2027 first quarter, with guidance projecting $91 billion for Q2. The company’s
GC=F opens 0.2% lower at $4,059.80 amid sustained U.S.-Iran airstrikes and surging oil prices. Gold August futures opened at $4,059.80 on July 15, down 0.2% from Tuesday’s close, as geopolitical risks failed to support the metal. Prices slipped to $4,035.40 in early tradin
The deal boosts Caprock’s client base and geographic reach while adding family office services and 30 employees. Caprock has acquired Venturi Private Wealth, a Texas-based wealth management firm managing $4bn in assets. The purchase strengthens Caprock’s presence in Austin
The bank’s net income jumped 58% to $5.58 billion, beating estimates as equities trading revenue soared 69% to $6.3 billion. Morgan Stanley reported second-quarter net revenue of $21.35 billion, a 27% increase from $16.8 billion a year earlier, driven by a 69% surge in equ
Morgan Stanley (MS) stock gained 1.2% in Wednesday premarket trading after Q2 earnings beat the Wall Street consensus, driven by a surge in investment banking and equities revenue, as well as growth in asset management revenue.
Goldman Sachs profit has surged in the second quarter (Q2) of 2026, benefitting from a booming trading environment and continued growth in asset and wealth management. The US-based bank reported net earnings of $6.63bn in the quarter ended 30 June 2026, a 78.2% surge from
AbbVie raises full-year guidance after Skyrizi and Rinvoq growth offsets Humira losses, while Baxter posts $900 million net loss and scraps dividend. AbbVie’s golden cross technical signal is widening, supported by a 2.8% dividend yield and rising moving averages. The comp
ASML reported second-quarter net sales of €9.3 billion on Wednesday, beating expectations, as the company raised its full-year revenue forecast for the second time this year on sustained demand for advanced AI chips. ASML's updated outlook calls for 2026 net sales of €43 b
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.